Category: Clinical Trials

Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID

Posted on | Posted on John Murphy | Leave a Comment on Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID

Jessica Polizzi, Jenna Tosto-Mancuso, Laura Tabacof, Jamie Wood, David Putrino Introduction: Long COVID involves debilitating symptoms, many of which mirror those observed with dysautonomia, and care must be taken with rehabilitation for autonomic dysfunction to avoid post-exertional malaise/post-exertional symptom exacerbation. Resonant breathing (breathing slowly at a defined rate of breaths per minute) requires less exertion and […]

Risk factors for long COVID revealed

Posted on | Posted on John Murphy | Leave a Comment on Risk factors for long COVID revealed

2024Source: Columbia University Irving Medical Center Summary: A new study sheds light on factors that may have predisposed some patients to recover more slowly after COVID.   Early in the pandemic, many people who had SARS-Cov-2 infection or COVID-19 began to report that they couldn’t shake off their symptoms even after a month or more — […]

What Does Recovery From COVID-19 Look Like?

Posted on | Posted on John Murphy | Leave a Comment on What Does Recovery From COVID-19 Look Like?

By Colleen Doherty, MD, 2024, Medically reviewed by Renee Nilan, MD, Very Well Health COVID-19—an infection caused by the SARS-CoV-2 virus—first appeared in late 2019 and can manifest in several ways, ranging from no or mild symptoms to severe or critical illness. While most people with COVID-19 fully recover, the timeline for this recovery process varies. Also, […]

NIH Documents Show $1.6 Billion Long COVID Initiative So Far Falls Short Of Goals

Posted on | Posted on John Murphy | Leave a Comment on NIH Documents Show $1.6 Billion Long COVID Initiative So Far Falls Short Of Goals

FRIDAY, JUN 14, 2024 – Authored by Megan Redshaw, J.D. via The Epoch Times  It’s been more than three years since Congress directed the National Institutes of Health (NIH) to investigate the long-term effects of COVID-19—and there are still no answers for the millions of Americans suffering from long COVID. The NIH launched the $1.15 […]

What is long COVID and who’s at risk? This NIH project may find out

Posted on | Posted on John Murphy | Leave a Comment on What is long COVID and who’s at risk? This NIH project may find out

Scientists with the RECOVER Initiative say they’re working as quickly as they can to find answers By Meghan Rosen, Staff Writer, Biological Sciences OCTOBER 24, 2022 AT 9:00 AM Science News You may have heard the big long COVID news that came out recently: A Scottish study reported that about half of people infected with SARS-CoV-2 have not […]

Five Bold Predictions for Long COVID in 2024

Posted on | Posted on user | Leave a Comment on Five Bold Predictions for Long COVID in 2024

Sara Novak, January 25, 2024 With a number of large-scale clinical trials underway and researchers on the hunt for new therapies, long COVID scientists are hopeful that this is the year patients — and doctors who care for them — will finally see improvements in treating their symptoms. Here are five bold predictions — all […]

How Pfizer Hid Nearly 80% of COVID Vaccine Trial Deaths From Regulators

Posted on | Posted on John Murphy | Leave a Comment on How Pfizer Hid Nearly 80% of COVID Vaccine Trial Deaths From Regulators

By Angelo DePalma, Ph.D. The Defender According to an analysis, published this month in the International Journal of Vaccine Theory, Practice, and Research, of Pfizer-BioNTech COVID-19 vaccine clinical trial data, the vaccine makers hid fatality data from regulators in order to qualify for Emergency Use Authorization. Pfizer-BioNTech delayed reporting vaccine-associated deaths among BNT162b2 clinical trial participants […]

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials

Posted on | Posted on John Murphy | Leave a Comment on Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials

Deborah A. Theodore, MD1; Angela R. Branche, MD2; Lily Zhang, PhD3; et alDaniel S. Graciaa, MD4; Madhu Choudhary, MD5; Timothy J. Hatlen, MD6; Raadhiya Osman, PhD7; Tara M. Babu, MD8; Samuel T. Robinson, PhD3; Peter B. Gilbert, PhD3,9;  Dean Follmann, PhD10;  Holly Janes, PhD3,9; James G. Kublin, MD3; Lindsey R. Baden, MD11; Paul Goepfert, MD12; Glenda E. Gray, MBBCh13,14; Beatriz Grinsztejn, MD, PhD15; Karen L. Kotloff, MD16,17; Cynthia L. Gay, MD18; Brett Leav, MD19; Jacqueline Miller, MD19; Ian Hirsch, PhD20; Jerald Sadoff, MD21; Lisa M. Dunkle, MD22; Kathleen M. Neuzil, MD17; Lawrence Corey, MD3,23; Ann R. Falsey, MD2; Hana M. El Sahly, MD24,25; Magdalena E. Sobieszczyk, MD1; Yunda Huang, PhD3,26; for the COVID-19 Prevention Network (CoVPN) JAMA Netw Open. 2023;6(7):e2323349. doi:10.1001/jamanetworkopen.2023.23349 Key Points Question  What clinical and demographic factors are associated with rates of COVID-19, severe COVID-19, and SARS-CoV-2 infection? Findings  In this secondary analysis of […]

COVID-19 Virus Levels In Wastewater Have Dropped

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Virus Levels In Wastewater Have Dropped

SEP 22, 2023 – 02:25 PM Authored by Naveen Athrappully via The Epoch Times  Wastewater COVID levels have shown a decline in recent weeks while the number of hospital admissions due to infections have seen an uptick. The levels of SARS-CoV-2 virus, which causes the COVID-19 infection, has dropped by 5 percent in the two weeks […]

COVID-19 Vaccine/Gene Therapy Controversies

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Vaccine/Gene Therapy Controversies

Since the introduction of the government sponsored warp speed development of mRNA injections for the prevention of COVID-19 illnesses in 2020, there has been little scrutiny of the efficacy and safety of these jabs. The medical profession seems disinterested in these subjects. However, there is a growing body of evidence that the mRNA injections do […]